Tag: type 2 diabetes
1. Women with a history of gestational diabetes who consumed 5.0-14.9 g/day of alcohol demonstrated a reduced risk of type 2 diabetes development compared to those without any alcohol consumption.
2. Beer and wine, but not liquor, were associated with lowering the risk of type 2 diabetes incidence among women...
1. This cross-sectional study discovered that the estimated prevalence of both type 1 and type 2 diabetes among youths in the United States increased from 2001 to 2017.
2. The most substantial increases were observed in non-Hispanic White and non-Hispanic Black youths for type 1 diabetes and non-Hispanic Black and...
1. Patients receiving tirzepatide (5, 10, or 15 mg) reported significantly greater reductions in HbA1c compared to daily insulin degludec at 52 weeks post-randomization.
2. Tirzepatide (5, 10, or 15 mg) was superior to insulin degludec for the bodyweight reductions at 52 weeks post-randomization.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Current...
1. Standard BMI thresholds associated with greater risk of diabetes varied across 57 low- and middle-income countries depending on geographical region.
2. Younger individuals are also at greater risk of diabetes depending on geographical region, notably for men aged 25-34 in sub-Saharan Africa.
Evidence Rating Level: 2 (Good)
Study Rundown: Body mass...
1. Tirzepatide was superior to placebo with regard to changes in HbA1c, serum glucose, body weight loss, and proportion of patients achieving HbA1c targets of less than 7.0%.
2. Compared to placebo, the proportion of adverse events with tirzepatide were mildly elevated.
Evidence Rating Level: 1 (Excellent)
Study Rundown: In many patients...
1. Sotagliflozin treatment was shown to increase the days-alive-and-out-of-hospital compared to placebo in patients with type 2 diabetes and heart failure.
2. Sotagliflozin treatment was shown to significantly decrease the rate of days dead compared to the placebo treatment.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have...
1. Widespread diabetes screening helps to identify asymptomatic patients with preserved renal function and low diabetes-associated cardiovascular risk.
2. New cardiovascular risk stratification strategies are needed given heterogeneous characteristics of patients with type 2 diabetes.
Evidence Rating Level: 2 (Good)
Study Rundown: In the last decade, New Zealand Ministry of Health has...
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new research evidence focused on wellness. Each week, we will report on articles examining different aspects of wellness, including (but not limited to) nutrition, sleep, reproductive health, substance use and...
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo.
2. Approximately two-thirds of patients on semaglutide 2.4 mg achieved a target HbA1c of 6.5% or less.
Evidence Rating Level: 1 (Excellent)
Study Rundown: There is strong overlap between weight gain and type 2 diabetes, with the...